Your browser doesn't support javascript.
loading
Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain.
Villarejo-Galende, Alberto; García-Arcelay, Elena; Piñol-Ripoll, Gerard; Del Olmo-Rodríguez, Antonio; Viñuela, Félix; Boada, Mercè; Franco-Macías, Emilio; de la Peña, Almudena Ibañez; Riverol, Mario; Puig-Pijoan, Albert; Abizanda-Soler, Pedro; Arroyo, Rafael; Baquero-Toledo, Miquel; Feria-Vilar, Inmaculada; Balasa, Mircea; Berbel, Ángel; Rodríguez-Rodríguez, Eloy; Vieira-Campos, Alba; García-Ribas, Guillermo; Rodrigo-Herrero, Silvia; Lleó, Albert; Maurino, Jorge.
Afiliación
  • Villarejo-Galende A; Department of Neurology, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (I+12), CIBERNED, Madrid, Spain.
  • García-Arcelay E; Medical Department, Roche Farma, Ribera del Loira 50, 28042, Madrid, Spain.
  • Piñol-Ripoll G; Unitat Trastorns Cognitius, Hospital Universitari de Santa Maria, Institut de Recerca Biomèdica de Lleida (IRBLLeida), Lleida, Spain.
  • Del Olmo-Rodríguez A; Department of Neurology, Hospital Universitario Dr. Peset, Valencia, Spain.
  • Viñuela F; Instituto Neurológico Andaluz, Hospital Victoria Eugenia, Unidad de Deterioro Cognitivo, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Boada M; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, CIBERNED, Barcelona, Spain.
  • Franco-Macías E; Dementia Unit, Department of Neurology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain.
  • de la Peña AI; Centro de Investigación de Parkinson, Policlínica Guipúzcoa, San Sebastián, Spain.
  • Riverol M; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Puig-Pijoan A; Cognitive Impairment and Movement Disorders Unit, Department of Neurology, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, Spain.
  • Abizanda-Soler P; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
  • Arroyo R; Department of Neurology, Hospital Universitario Quirónsalud, Madrid, Spain.
  • Baquero-Toledo M; Department of Neurology, Hospital Universitari i Politècnic La Fe, Institut d'Investigació Sanitaria La Fe, Valencia, Spain.
  • Feria-Vilar I; Department of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
  • Balasa M; Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Berbel Á; Department of Neurology, Hospital Central de la Cruz Roja, Madrid, Spain.
  • Rodríguez-Rodríguez E; Department of Neurology, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain.
  • Vieira-Campos A; Department of Neurology, Hospital Universitario de La Princesa, Madrid, Spain.
  • García-Ribas G; Department of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Rodrigo-Herrero S; Department of Neurology, Hospital Universitario Juan Ramón Jiménez, Huelva, Spain.
  • Lleó A; Memory Unit, Department of Neurology, Hospital de La Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Maurino J; Medical Department, Roche Farma, Ribera del Loira 50, 28042, Madrid, Spain. jorge.maurino@roche.com.
Neurol Ther ; 11(3): 1183-1192, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35648383
ABSTRACT

INTRODUCTION:

Limited information is available on people's experiences of living with Alzheimer's disease (AD) at earlier stages. This study assessed awareness of diagnosis among people with early-stage AD and its impact on different person-centered outcome measures.

METHODS:

We conducted an observational, cross-sectional study in 21 memory clinics in Spain. Persons aged 50-90 years, diagnosed with prodromal or mild AD (NIA/AA criteria), a Mini Mental State Examination (MMSE) score ≥ 22, and a Clinical Dementia Rating-Global score (CDR-GS) of 0.5 or 1.0 were recruited. The Representations and Adjustment to Dementia Index (RADIX) was used to assess participants' beliefs about their condition and its consequences.

RESULTS:

A total of 149 persons with early-stage AD were studied. Mean (SD) age was 72.3 (7.0) years and 50.3% were female. Mean duration of AD was 1.4 (1.8) years. Mean MMSE score was 24.6 (2.1) and 87.2% had a CDR-GS score of 0.5. Most participants (n = 84, 57.5%) used a descriptive term related to specific AD symptoms (e.g., memory difficulties) when asked what they called their condition. Participants aware of their diagnosis using the term AD (n = 66, 45.2%) were younger, had more depressive symptoms, and poorer life satisfaction and quality of life compared to those without awareness of their specific diagnosis. Practical and emotional consequences RADIX scores showed a significant negative correlation with Quality of Life in Alzheimer's Disease score (rho = - 0.389 and - 0.413, respectively; p < 0.0001). Years of education was the only predictor of awareness of AD diagnosis [OR = 1.04 (95% CI 1.00-1.08); p = 0.029].

CONCLUSIONS:

Awareness of diagnosis was a common phenomenon in persons with early-stage AD negatively impacting their quality of life. Understanding illness representations in earlier stages may facilitate implementing optimized care that supports improved quality of life and well-being.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Neurol Ther Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Neurol Ther Año: 2022 Tipo del documento: Article País de afiliación: España
...